These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 31973030)
1. Revealing and Harnessing Tumour-Associated Microglia/Macrophage Heterogeneity in Glioblastoma. Pires-Afonso Y; Niclou SP; Michelucci A Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31973030 [No Abstract] [Full Text] [Related]
2. Elucidating tumour-associated microglia/macrophage diversity along glioblastoma progression and under ACOD1 deficiency. Pires-Afonso Y; Muller A; Grzyb K; Oudin A; Yabo YA; Sousa C; Scafidi A; Poli A; Cosma A; Halder R; Coowar D; Golebiewska A; Skupin A; Niclou SP; Michelucci A Mol Oncol; 2022 Sep; 16(17):3167-3191. PubMed ID: 35838338 [TBL] [Abstract][Full Text] [Related]
3. Tumor-associated microglia and macrophages in glioblastoma: From basic insights to therapeutic opportunities. Wang G; Zhong K; Wang Z; Zhang Z; Tang X; Tong A; Zhou L Front Immunol; 2022; 13():964898. PubMed ID: 35967394 [TBL] [Abstract][Full Text] [Related]
5. The Heterogeneity of Tumour-Associated Macrophages Contributes to the Recurrence and Outcomes of Glioblastoma Patients. Xuan Z; Fang L; Zhang G; Zhang X; Jiang J; Wang K; Huang P J Mol Neurosci; 2023 Jan; 73(1):1-14. PubMed ID: 36542317 [TBL] [Abstract][Full Text] [Related]
6. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth. Zhou W; Ke SQ; Huang Z; Flavahan W; Fang X; Paul J; Wu L; Sloan AE; McLendon RE; Li X; Rich JN; Bao S Nat Cell Biol; 2015 Feb; 17(2):170-82. PubMed ID: 25580734 [TBL] [Abstract][Full Text] [Related]
7. Glioblastoma-instructed microglia transition to heterogeneous phenotypic states with phagocytic and dendritic cell-like features in patient tumors and patient-derived orthotopic xenografts. Yabo YA; Moreno-Sanchez PM; Pires-Afonso Y; Kaoma T; Nosirov B; Scafidi A; Ermini L; Lipsa A; Oudin A; Kyriakis D; Grzyb K; Poovathingal SK; Poli A; Muller A; Toth R; Klink B; Berchem G; Berthold C; Hertel F; Mittelbronn M; Heiland DH; Skupin A; Nazarov PV; Niclou SP; Michelucci A; Golebiewska A Genome Med; 2024 Apr; 16(1):51. PubMed ID: 38566128 [TBL] [Abstract][Full Text] [Related]
8. Programmed Cell Death 10 Mediated CXCL2-CXCR2 Signaling in Regulating Tumor-Associated Microglia/Macrophages Recruitment in Glioblastoma. Zhang Q; Wang J; Yao X; Wu S; Tian W; Gan C; Wan X; You C; Hu F; Zhang S; Zhang H; Zhao K; Shu K; Lei T Front Immunol; 2021; 12():637053. PubMed ID: 34108959 [TBL] [Abstract][Full Text] [Related]
9. Macrophages and microglia: the cerberus of glioblastoma. Buonfiglioli A; Hambardzumyan D Acta Neuropathol Commun; 2021 Mar; 9(1):54. PubMed ID: 33766119 [TBL] [Abstract][Full Text] [Related]
10. Myeloid Cells in Glioblastoma Microenvironment. De Leo A; Ugolini A; Veglia F Cells; 2020 Dec; 10(1):. PubMed ID: 33374253 [TBL] [Abstract][Full Text] [Related]
11. Neuroinflammation in Glioblastoma: The Role of the Microenvironment in Tumour Progression. Nóbrega AHL; Pimentel RS; Prado AP; Garcia J; Frozza RL; Bernardi A Curr Cancer Drug Targets; 2024; 24(6):579-594. PubMed ID: 38310461 [TBL] [Abstract][Full Text] [Related]
12. Interactions between tumor-associated macrophages and tumor cells in glioblastoma: unraveling promising targeted therapies. Morisse MC; Jouannet S; Dominguez-Villar M; Sanson M; Idbaih A Expert Rev Neurother; 2018 Sep; 18(9):729-737. PubMed ID: 30099909 [TBL] [Abstract][Full Text] [Related]
13. Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival. Poli A; Wang J; Domingues O; Planagumà J; Yan T; Rygh CB; Skaftnesmo KO; Thorsen F; McCormack E; Hentges F; Pedersen PH; Zimmer J; Enger PØ; Chekenya M Oncotarget; 2013 Sep; 4(9):1527-46. PubMed ID: 24127551 [TBL] [Abstract][Full Text] [Related]
14. Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment. Li TF; Li K; Wang C; Liu X; Wen Y; Xu YH; Zhang Q; Zhao QY; Shao M; Li YZ; Han M; Komatsu N; Zhao L; Chen X J Control Release; 2017 Dec; 268():128-146. PubMed ID: 29051064 [TBL] [Abstract][Full Text] [Related]
15. Microglia and Brain Macrophages as Drivers of Glioma Progression. Zheng Y; Graeber MB Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555253 [TBL] [Abstract][Full Text] [Related]
16. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis. Feng X; Szulzewsky F; Yerevanian A; Chen Z; Heinzmann D; Rasmussen RD; Alvarez-Garcia V; Kim Y; Wang B; Tamagno I; Zhou H; Li X; Kettenmann H; Ransohoff RM; Hambardzumyan D Oncotarget; 2015 Jun; 6(17):15077-94. PubMed ID: 25987130 [TBL] [Abstract][Full Text] [Related]
18. Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy. Khan F; Pang L; Dunterman M; Lesniak MS; Heimberger AB; Chen P J Clin Invest; 2023 Jan; 133(1):. PubMed ID: 36594466 [TBL] [Abstract][Full Text] [Related]
19. The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma. Zhang L; Jiang Y; Zhang G; Wei S Front Immunol; 2023; 14():1238233. PubMed ID: 37731483 [TBL] [Abstract][Full Text] [Related]
20. Galectin-3 depletion tames pro-tumoural microglia and restrains cancer cells growth. Rivera-Ramos A; Cruz-Hernández L; Talaverón R; Sánchez-Montero MT; García-Revilla J; Mulero-Acevedo M; Deierborg T; Venero JL; Sarmiento Soto M Cancer Lett; 2024 Jun; 591():216879. PubMed ID: 38636895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]